Schizophrenic Patients Taking Part in Integrated Care Program (CARE I)

AstraZeneca logo

AstraZeneca

Status

Terminated

Conditions

Schizophrenia
Schizoaffective Disorder
Psychotic Disorder Not Otherwise Specified
Schizophreni-form Disorder
Delusional Disorder

Study type

Observational

Funder types

Industry

Identifiers

NCT00617214
NIS-NDE-SER-2007/1

Details and patient eligibility

About

Purpose of this non-interventional study (NIS) is to assess the effect of the participation in an integrated care program on treatment outcomes in patients treated with Seroquel for schizophrenia.

Enrollment

20 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Outpatients suffering from schizophrenia, schizoaffective disorder, schizophreni-form disorder, delusional disorder or psychotic disorder not otherwise specified
  • Age 18 - 65 years
  • Current stable treatment with Seroquel according to SmPC since at least 2 months
  • Given consent to take part in an integrated care program prior to study startWritten informed consent to take part in this NIS

Exclusion criteria

  • Presence of any contraindication as described in the SmPC
  • Cancellation of participation in the integrated care program

Trial design

20 participants in 1 patient group

All
Description:
Schizophrenic outpatients who are treated with Seroquel IR and who are additionally intended to start with an integrated care program

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems